Literature DB >> 11049911

Characteristics of ropivacaine block of Na+ channels in rat dorsal root ganglion neurons.

A Oda1, H Ohashi, S Komori, H Iida, S Dohi.   

Abstract

UNLABELLED: When used for epidural anesthesia, ropivacaine can produce a satisfactory sensory block with a minor motor block. We investigated its effect on tetrodotoxin-sensitive (TTX-S) and tetrodotoxin-resistant (TTX-R) Na(+) currents in rat dorsal root ganglion (DRG) neurons to elucidate the mechanisms underlying the above effects. Whole-cell patch-clamp recordings were made from enzymatically dissociated neurons from rat DRG. A TTX-S Na(+) current was recorded preferentially from large DRG neurons and a TTX-R Na(+) current preferentially from small ones. Ropivacaine shifted the activation curve for the TTX-R Na(+) channel in the depolarizing direction and the inactivation curve for both types of Na(+) channel in the hyperpolarizing direction. Ropivacaine blocked TTX-S and TTX-R Na(+) currents, but its half-maximum inhibitory concentration (IC(50)) was significantly lower for the latter current (116 +/- 35 vs 54 +/- 14 microM; P: < 0.01); similar IC(50) values were obtained with the (R)-isomer of ropivacaine. Ropivacaine produced a use-dependent block of both types of Na(+) channels. Ropivacaine preferentially blocks TTX-R Na(+) channels over TTX-S Na(+) channels. We conclude that because TTX-R Na(+) channels exist mainly in small DRG neurons (which are responsible for nociceptive sensation), such selective action of ropivacaine could underlie the differential block observed during epidural anesthesia with this drug. IMPLICATIONS: Whole-cell patch-clamp recordings of tetrodotoxin-sensitive and tetrodotoxin-resistant Na(+) currents in rat dorsal root ganglion neurons showed ropivacaine preferentially blocked tetrodotoxin-resistant Na(+) channels over tetrodotoxin-sensitive Na(+) channels. This could provide a desirable differential sensory blockade during epidural anesthesia using ropivacaine.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11049911     DOI: 10.1097/00000539-200011000-00031

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  5 in total

1.  Pharmacological modulation of brain Nav1.2 and cardiac Nav1.5 subtypes by the local anesthetic ropivacaine.

Authors:  Hui-Wen Cheng; Hong-Tian Yang; Jing-Jing Zhou; Yong-Hua Ji; Hong-Yan Zhu
Journal:  Neurosci Bull       Date:  2010-08       Impact factor: 5.203

2.  Median Effective Concentration of Ropivacaine for Femoral Nerve Block Maintaining Motor Function During Knee Arthroscopy in Two Age Groups.

Authors:  Yan-Lei Tai; Li Peng; Ying Wang; Zi-Jun Zhao; Ya-Nan Li; Chun-Ping Yin; Zhi-Yong Hou; De-Cheng Shao; Ya-Hui Zhang; Qiu-Jun Wang
Journal:  J Pain Res       Date:  2022-06-07       Impact factor: 2.832

3.  Pulmonary effects of bupivacaine and ropivacaine in parturients undergoing spinal anesthesia for elective cesarean delivery.

Authors:  Guiqi Geng; Wenhui Li; Shaoqiang Huang
Journal:  Int J Clin Exp Med       Date:  2014-05-15

4.  [Peridural application of ropivacaine and clonidine for pain therapy after prostatectomy].

Authors:  M Voje; A Manohin
Journal:  Schmerz       Date:  2008-12       Impact factor: 1.107

5.  Epidural sustained release ropivacaine prolongs anti-allodynia and anti-hyperalgesia in developing and established neuropathic pain.

Authors:  Teng-Fei Li; Hui Fan; Yong-Xiang Wang
Journal:  PLoS One       Date:  2015-01-24       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.